The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
As expected, President Trump signed an executive order announcing his intention to withdraw the U.S. from the World Health Organization. For the U.S., the implications [aren’t] clear and immediate but could also be significant. By not being at the table, the U.S. will cede this role to others—China in particular—and take itself out of influencing international negotiations.
Amid an ongoing FDA re-review of mifepristone, awareness of the safety and prevalence of the abortion pill remains limited. This KFF poll also finds that the voters who say abortion policy is an important issue for 2026 midterm candidates to discuss are disproportionately Democrats.
With funding for additional COVID-19 support at a stalemate in Congress, a new KFF analysis looks at potential scenarios that United States might face if a 4th COVID-19 vaccine dose is recommended to the public. The analysis finds that the U.S. government does not have enough funding to purchase vaccine doses remaining to fully cover the population under any of the predicted scenarios. If 4th doses are authorized and recommended for all ages, there will…
This report examines COVID-19 misinformation and finds that nearly eight in ten adults either believe or are unsure about at least one false statement about COVID-19 or the vaccines. It also examines the news and social media sources the public trusts for information on the virus, and the relationship between news sources and belief in misinformation.
Following the recent US Food & Drug Administration’s (FDA) authorization and the Centers for Disease Control and Prevention’s (CDC) recommendation, children ages 5-11 are now eligible to receive Pfizer-BioNTech’s COVID-19 vaccine. There may be unique challenges to vaccinating young children, particularly those from low-income families who may face additional barriers to access. State Medicaid programs and Medicaid managed care plans are looking at a range of policy options to facilitate access to vaccines for young,…
In this Axios column, Drew Altman takes on the idea that communities of color are behind the problem of the unvaccinated in the U.S.
This report tracks the public's COVID-19 vaccine intentions, including parents' intentions for their children ages 5-11 who may soon become eligible to get a vaccine. It also examines workers' experiences with and views toward employer vaccine mandates and the public's holiday plans heading into the second holiday season under the pandemic.
The side-by-side comparison tool provides a quick overview of former President Trump's and Vice President Harris' records, positions, public statements, and proposed policies on a range of key health care topics.
Public is Less Optimistic and More Frustrated with State of Vaccinations Now Than in January Nearly a quarter (23%) of fully vaccinated adults have already received a COVID-19 booster shot, more than double the share who had done so in October (10%), the latest KFF COVID-19 Vaccine Monitor report reveals. Most other vaccinated adults say they definitely (37%) or probably (19%) will get a booster shot as recommended, while about a fifth say they will…
This data note provides an analysis of COVID-19 vaccination rates among 5-11 year-old children across the states. Overall, we find wide variation in share of children who have received at least one dose of a COVID-19 vaccine across the states.
© 2026 KFF